Characterizing the Complexity of Senior Care Pharmacy.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Works matching IS 26399636 AND DT 2023 AND VI 38 AND IP 12
Results: 7
1
2
Federal and State Programs and Resources for Chronic Kidney Disease.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 12, p. 524, doi. 10.4140/TCP.n.2023.524
- By:
- Publication type:
- Article
3
New Drugs: Faricimab-svoa (Vabysmo™) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti™) for Glaucoma and Ocular Hypertension.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 12, p. 497, doi. 10.4140/TCP.n.2023.497
- By:
- Publication type:
- Article
4
Considerations on the Weight Loss-Associated Glucagon-like Peptide-1 Receptor Agonists for Older People.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 12, p. 493, doi. 10.4140/TCP.n.2023.493
- By:
- Publication type:
- Article
5
Diversification and Expansion of Clinical Pharmacy Services: Is it Time for Senior Care Pharmacists to Step Into the Light?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
6
The Effect of PharmacistInitiated Deprescribing Interventions in Older People: A Narrative Review of Randomized Controlled Trials.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 12, p. 506, doi. 10.4140/TCP.n.2023.506
- By:
- Publication type:
- Article
7
Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 12, p. 501, doi. 10.4140/TCP.n.2023.501
- By:
- Publication type:
- Article